|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | Suite 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 14267-12
|
||||||||
|
6. House ID# 326350000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Katie Tenoever |
Date | 10/20/2020 10:38:07 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R.7676/ S.4106 - "Health Care PRICE Transparency Act" - Oppose public disclosure of confidential hospital negotiated rates with payers
H.R. 1384 - "Medicare For All Act of 2019", S.1129 - Oppose government-run national health insurance
H.R. 2085/ S.1033 "Consumer Health Options and Insurance Competition Enhancement Act (CHOICE) Act", H.R. 2000/S.981 - "Medicare-X Choice Act of 2019" - Oppose public option
S. 1895 - "Lower Health Care Costs Act" - Support protecting patients from surprise billing and oppose government rate setting. Advocated for appropriate transparency and contracting flexibility.
S.1531 "Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019", H.R. 3630 "No Surprises Act", H.R. 3502 "Protecting People From Surprise Medical Bills Act", H.R. 5800 Ban Surprise Billing Act, H.R. 5826 "Consumer Protections Against Surprise Medical Bills Act of 2020" - Advocate to protect patients from surprise billing and oppose government rate setting.
H.R. 6837/ S. 3750 "Medicare Accelerated and Advance Payments Improvement Act of 2020" - Support amended payment terms for eligible health care providers under the Medicare Accelerated and Advance Payments Program
H.R. 6800 "Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act" - Support Division C, Health Provisions for Medicare and Medicaid that support health care providers and patients
H.R. 6365/ S. 3559 "Immediate Relief for Rural Facilities and Providers Act of 2020" - Support expansion of access to telehealth programs for tax paying rural hospitals
H.R. 7059 "Coronavirus Provider Protection Act" - Evaluated and advocated for improvements to legislation relating to liability protections during COVID-19
S. 4317 - "SAFE TO WORK Act" - Develop proposal to protect hospitals, healthcare professionals and facilities from liability due to COVID-19
H.R. 7819 / S. 4525 - " Eliminating the Provider Relief Fund Tax Penalties Act of 2020" - Support technical corrections to Provider Relief Fund to ensure funds received are not taxable
H.R. 8337 - "Continuing Appropriations Act, 2021 and Other Extensions Act" - Support passage of continuing resolution, including language to improve repayment terms of Medicare Accelerated and Advance Payment Programs.
H.R. 8061 - "Community Immunity During COVID-19 Act of 2020" - Support legislation that increases community access and awareness to vaccinations.
S. 4421 - "The Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act" - Support legislation that provides temporary licensing reciprocity for health care professionals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 3062/S. 2860 - "Patient Access to Higher Quality Health Care Act of 2019" - Oppose efforts to repeal certain provisions relating to the Medicare exception to the prohibition on certain physician referrals for hospitals.
H.R. 2552 - "Protecting Local Access to Care for Everyone (PLACE) Act" - Support legislation to prevent site neutral cuts.
Support access to affordable prescription drugs.
H.R. 3107 - "Improving Seniors' Timely Access to Care Act" - Support legislation that streamlines and standardizes prior authorization under the Medicare Advantage program.
Sought moratorium on proposed Medicaid Fiscal Accountability Regulation
H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act - Support Division C, Health Provisions for Medicare and Medicaid that support health care providers and patients
Post-Acute Care - Refresh the unified PAC PPS timeline and process under the IMPACT Act, Sought Congressional support for an IMPACT Act implementation/ unified payment timeline reset
Qualifying APM Professional Threshold - Support request of House Leadership to address impending MACRA changes that could derail the movement to value-based health care and alternative payment models
H.R. 7663 - "Protecting Access to Post-COVID-19 Telehealth Act of 2020" - Support broader access to Medicare telehealth services
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code COM
16. Specific lobbying issues
H.R. 6474 "Healthcare Broadband Expansion During COVID-19 Act" - Seek expansion of eligibility criteria for FCC COVID-19 Telehealth Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 6788/ S. 3599 "Healthcare Workforce Resilience Act" - Support reclaiming unused immigrant Visas to ensure availability of qualified medical personnel
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |